10:15 am – 11:00 am – How Much is Right for You: The Science of CBD Dosing
One of the challenges in the emerging CBD market is the lack of robust clinical research that can be used to guide dosing guidelines. This is especially problematic in people with comorbidities or on other medications who would like to explore taking these products medicinally too. Even so, crowdsourcing the anecdotal data has allowed companies to review by developing a functional measure of how much CBD is needed for different conditions. This system, albeit lacking in strong foundations in clinical trials, in some ways is good enough. But, when it comes to a product we want to promote as medication, we have a responsibility to produce real data from which to work off of.
11:15 am – 12:00 pm – Making the Claim: How to Build an Effective Brand through Compliant Labelling and Packaging
With various levels of legalization taking place nationwide, ensuring that your messaging falls within legal guidelines is crucial. From packaging and advertising content to marketing initiatives and sales collateral there are a number of pitfalls CBD companies are liable to make when discussing the plant and its products. One incorrectly used word could potentially result in fines, shutdowns, and more. While clever packaging can help firms effectively deliver messages while ensuring product integrity and safety. Here, we give you the ins and outs of precisely what can and cannot be said in your messaging, packaging, and branding. Stop having to worry about whether or not you are in compliance by listening to what the experts have to say.
12:00 pm – 12:30 pm – LUNCH BREAK
During this presentation, you will hear how a medical cannabis physician managed/treated his first COVID-19 patient with phytocannabinoids, plant medicine, vitamins, minerals, and “conventional medicine”. Along with treatment, Joseph Rosado will provide his reflections on what lessons were learned and what opportunities presented themselves post-COVID-19.
1:30 pm – 2:15 pm – Legal Cultivation of Psilocybin; How Will It Be Regulated?
The use and understanding of psilocybin are on the rise, and with this comes a need for new rules and regulations. As more states and regions ease restrictions, methods for legal cultivation are needed to maintain a grasp on a soon expanding market. This panel will dive into the potential ways in which legal psilocybin cultivation will be regulated by taking a look at currently established standards alongside the potential outlook in the near future. Legal regulations are an integral aspect for anyone looking to create business opportunities within the world of psychedelics and also for personal use. Here, we will take an in-depth assessment of both.
2:30 pm – 3:15 pm – Dueling Panel: The Delta 8 Showdown
Delta-8 is great or Delta-8 is taint?! Join this much anticipated panel consortium to hear the evidence and arguments for and against. Is it Safe or unsafe? Should Delta 8 be legal or illegal?
Currently, the hot cannabinoid of the moment is Delta-8 THC. Delta-8 THC is a psychoactive compound—as in, it gets you high—which is legal in most states. Or, if not legal, then at least widely available. Therefore, this puts Delta-8 in a bit of a gray area.
To elaborate, with the structure of the law—everything hemp is legal except THC—created what is seen by many producers as a loophole that allows the production and sale of Delta-8 THC, because it’s ever-so-slightly chemically distinct from the banned Delta-9 THC.
You be the judge as these panels duel it out!